Clostridium Difficile - part 3
Jan 23, 2019•13 min•Ep. 54
Episode description
Many of the latest studies in the 2017-2018 timeframe are reviewed. The importance of looking at the eosinophil count on the CBC, probiotic future directions, microbiome transplant options, antibody treatment (bezlotoxumab), "penicillin allergic" patients, and a brief mention of available testing.
For the best experience, listen in Metacast app for iOS or Android
